-
公开(公告)号:EP3728286A1
公开(公告)日:2020-10-28
申请号:EP18833038.5
申请日:2018-12-20
申请人: MedImmune Limited
-
2.GIP AND GLP-1 RECEPTOR DUAL-AGONISTS FOR THE TREATMENT OF DIABETES 审中-公开
标题翻译: GIP和GLP-1受体双激动剂治疗糖尿病公开(公告)号:EP3033355A1
公开(公告)日:2016-06-22
申请号:EP14752848.3
申请日:2014-08-15
申请人: Medimmune Limited
发明人: BEDNAREK, Maria , COLLINSON, Andie , HORNIGOLD, David , O'BRIEN, Siobhan , PAPWORTH, Monika , RAVN, Peter , SERMADIRAS, Isabelle
IPC分类号: C07K14/605 , C07K14/575 , C12N15/62
CPC分类号: C07K14/605 , A61K9/0019 , A61K38/2235 , A61K38/26 , A61K39/3955 , A61K45/06 , A61K2039/505 , A61K2039/54 , C07K14/57563 , C07K14/645 , C07K16/26 , C07K2317/524 , C07K2317/526 , C07K2317/71 , C07K2317/75 , C07K2317/94 , C07K2319/30
摘要: This disclosure provides GIP/GLP-1 dual agonist polypeptides for the treatment of hypoglycemic conditions,
e .
g ., type-2 diabetes.
-